PIK3CA and malignant colon neoplasm: Following in vivo infusions of [13C5]-glutamine in mice bearing subcutaneous colon cancer xenografts, we further verified that labeling from glutamine to most tricarboxylic acid cycle intermediates was higher in PIK3CA-mutant subcutaneous xenograft tumors than in wild-type PIK3CA tumors.32